CEO of Ocular Therapeutix
CEO of Ocular Therapeutix
Quick Links
O
Pravin U. Dugel, M.D.
CEO of Ocular Therapeutix
Education
B.A. from Columbia University in Comparative Literature and Molecular Biology; M.D. from UCLA School of Medicine.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
April 14, 1964 - 61 years ago
CEO of Ocular Therapeutix for
1 year 1 month (Apr 2024 - Present)
Previous Experience
Dr. Dugel previously served as President of IVERIC bio, Inc. and as Executive Vice President, Chief Strategy and Business Officer of IVERIC.
Rivals
Competitors/colleagues of Pravin U. Dugel, M.D.
Holdings
See how much did Pravin U. Dugel, M.D. make over time.
Holdings and trades for CEO of Ocular Therapeutix
Holdings and trades for CEO of Ocular Therapeutix
Mar 18, 2025
Total Stock Sold
$503.63K
OCUL
$503.63K
63,186 OCUL shares
What if they kept their stock?
If Pravin U. Dugel, M.D. didn't sell their stock, today they would have:
Extra OCUL63,186 shares worth $447.99K.
This is -11.05% and $55.64K less than what they got when they sold the stock.
Insider Trading
See recent insider trades of Pravin U. Dugel, M.D..
OCUL
$186.33K
OCUL at $9.01/share
Nov 25, 2024
Sale
OCUL
$188.34K
OCUL at $9.02/share
Aug 23, 2024
Sale
OCUL
$125.21K
OCUL at $5.79/share
May 23, 2024
Sale
OCUL
854,979 shares
OCUL
Feb 22, 2024
Received
Compensation History
See how much did Pravin U. Dugel, M.D. make over time.
No compensation data available for Pravin U. Dugel, M.D. yet. Come back soon!
Other Ocular Therapeutix CEOs
Here are other CEOs of Ocular Therapeutix